pharmaceuticals-and-healthcare

EMEA (Europe, Middle East and Africa) Antibody Drug Conjugate Market Report 2017


Published On : Apr 2017

Category : Pharmaceutical

No. of Pages : 118 pages

  • $4000
  • $8000

Please click below to avail discount on this report

In this report, the EMEA Antibody Drug Conjugate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Antibody Drug Conjugate for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Antibody Drug Conjugate market competition by top manufacturers/players, with Antibody Drug Conjugate sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Seattle Genetics/Takeda
Roche
ImmunoGen
Immunomedics
Pfizer
Celldex Therapeutics
Millennium Pharmaceuticals
Bayer HealthCare
Mersana Therapeutics
Heidelberg Pharma
Oxford BioTherapeutics
Takeda Pharmaceutical Company Limited

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
Adcetris
Kadcyl

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Pcs), market share and growth rate of Antibody Drug Conjugate for each application, including
Hospital
Research Institutions

In the recent times, the global market for Emea europe middle east and africa antibody drug conjugate market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Emea europe middle east and africa antibody drug conjugate market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Emea europe middle east and africa antibody drug conjugate market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the Emea europe middle east and africa antibody drug conjugate market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Emea europe middle east and africa antibody drug conjugate market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Emea europe middle east and africa antibody drug conjugate market report 2017, including the definition, classification, and industry chain structure of Emea europe middle east and africa antibody drug conjugate market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Emea europe middle east and africa antibody drug conjugate market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Emea europe middle east and africa antibody drug conjugate market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Emea europe middle east and africa antibody drug conjugate market report 2017, implemented in each of the geographical segments. The predominant applications of the Emea europe middle east and africa antibody drug conjugate market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Emea europe middle east and africa antibody drug conjugate market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Emea europe middle east and africa antibody drug conjugate market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Antibody Drug Conjugate
Figure EMEA Antibody Drug Conjugate Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Antibody Drug Conjugate Sales Volume Market Share by Type (Product Category) in 2016
Figure Adcetris Product Picture
Figure Kadcyl Product Picture
Figure EMEA Antibody Drug Conjugate Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Antibody Drug Conjugate by Application in 2016
Figure Hospital Examples
Figure Research Institutions Examples
Figure EMEA Antibody Drug Conjugate Market Size (Million USD) by Region (2012-2022)
Figure Europe Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Antibody Drug Conjugate Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Antibody Drug Conjugate Revenue (Million USD) Status and Forecast by Countries
Figure Africa Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Antibody Drug Conjugate Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Antibody Drug Conjugate Sales Volume and Growth Rate (2012-2022)
Figure EMEA Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Antibody Drug Conjugate Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Antibody Drug Conjugate Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Antibody Drug Conjugate Sales Share by Players (2012-2017)
Figure 2016 Antibody Drug Conjugate Sales Share by Players
Figure 2017 Antibody Drug Conjugate Sales Share by Players
Figure EMEA Antibody Drug Conjugate Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Antibody Drug Conjugate Revenue (Million USD) by Players (2012-2017)
Table EMEA Antibody Drug Conjugate Revenue Share by Players (2012-2017)
Table 2016 EMEA Antibody Drug Conjugate Revenue Share by Players
Table 2017 EMEA Antibody Drug Conjugate Revenue Share by Players
Table EMEA Antibody Drug Conjugate Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Antibody Drug Conjugate Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Antibody Drug Conjugate Sales Share by Type (2012-2017)
Figure Sales Market Share of Antibody Drug Conjugate by Type (2012-2017)
Figure EMEA Antibody Drug Conjugate Sales Market Share by Type (2012-2017)
Table EMEA Antibody Drug Conjugate Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Antibody Drug Conjugate Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antibody Drug Conjugate by Type in 2016
Table EMEA Antibody Drug Conjugate Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Antibody Drug Conjugate Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Antibody Drug Conjugate Sales Share by Application (2012-2017)
Figure Sales Market Share of Antibody Drug Conjugate by Application (2012-2017)
Figure EMEA Antibody Drug Conjugate Sales Market Share by Application in 2016
Table EMEA Antibody Drug Conjugate Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Antibody Drug Conjugate Sales Share by Region (2012-2017)
Figure Sales Market Share of Antibody Drug Conjugate by Region (2012-2017)
Figure EMEA Antibody Drug Conjugate Sales Market Share in 2016
Table EMEA Antibody Drug Conjugate Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Antibody Drug Conjugate Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Antibody Drug Conjugate by Region (2012-2017)
Figure EMEA Antibody Drug Conjugate Revenue Market Share Regions in 2016
Table EMEA Antibody Drug Conjugate Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Antibody Drug Conjugate Revenue and Growth Rate (2012-2017)
Table Europe Antibody Drug Conjugate Sales (K Pcs) by Type (2012-2017)
Table Europe Antibody Drug Conjugate Market Share by Type (2012-2017)
Figure Europe Antibody Drug Conjugate Market Share by Type in 2016
Table Europe Antibody Drug Conjugate Sales (K Pcs) by Application (2012-2017)
Table Europe Antibody Drug Conjugate Market Share by Application (2012-2017)
Figure Europe Antibody Drug Conjugate Market Share by Application in 2016
Table Europe Antibody Drug Conjugate Sales (K Pcs) by Countries (2012-2017)
Table Europe Antibody Drug Conjugate Sales Market Share by Countries (2012-2017)
Figure Europe Antibody Drug Conjugate Sales Market Share by Countries (2012-2017)
Figure Europe Antibody Drug Conjugate Sales Market Share by Countries in 2016
Table Europe Antibody Drug Conjugate Revenue (Million USD) by Countries (2012-2017)
Table Europe Antibody Drug Conjugate Revenue Market Share by Countries (2012-2017)
Figure Europe Antibody Drug Conjugate Revenue Market Share by Countries (2012-2017)
Figure Europe Antibody Drug Conjugate Revenue Market Share by Countries in 2016
Figure Germany Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Antibody Drug Conjugate Sales (K Pcs) by Type (2012-2017)
Table Middle East Antibody Drug Conjugate Market Share by Type (2012-2017)
Figure Middle East Antibody Drug Conjugate Market Share by Type (2012-2017)
Table Middle East Antibody Drug Conjugate Sales (K Pcs) by Applications (2012-2017)
Table Middle East Antibody Drug Conjugate Market Share by Applications (2012-2017)
Figure Middle East Antibody Drug Conjugate Sales Market Share by Application in 2016
Table Middle East Antibody Drug Conjugate Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Antibody Drug Conjugate Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Antibody Drug Conjugate Sales Volume Market Share by Countries in 2016
Table Middle East Antibody Drug Conjugate Revenue (Million USD) by Countries (2012-2017)
Table Middle East Antibody Drug Conjugate Revenue Market Share by Countries (2012-2017)
Figure Middle East Antibody Drug Conjugate Revenue Market Share by Countries (2012-2017)
Figure Middle East Antibody Drug Conjugate Revenue Market Share by Countries in 2016
Figure Saudi Arabia Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Antibody Drug Conjugate Sales (K Pcs) by Type (2012-2017)
Table Africa Antibody Drug Conjugate Sales Market Share by Type (2012-2017)
Figure Africa Antibody Drug Conjugate Sales Market Share by Type (2012-2017)
Figure Africa Antibody Drug Conjugate Sales Market Share by Type in 2016
Table Africa Antibody Drug Conjugate Sales (K Pcs) by Application (2012-2017)
Table Africa Antibody Drug Conjugate Sales Market Share by Application (2012-2017)
Figure Africa Antibody Drug Conjugate Sales Market Share by Application (2012-2017)
Table Africa Antibody Drug Conjugate Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Antibody Drug Conjugate Sales Market Share by Countries (2012-2017)
Figure Africa Antibody Drug Conjugate Sales Market Share by Countries (2012-2017)
Figure Africa Antibody Drug Conjugate Sales Market Share by Countries in 2016
Table Africa Antibody Drug Conjugate Revenue (Million USD) by Countries (2012-2017)
Table Africa Antibody Drug Conjugate Revenue Market Share by Countries (2012-2017)
Figure Africa Antibody Drug Conjugate Revenue Market Share by Countries (2012-2017)
Figure Africa Antibody Drug Conjugate Revenue Market Share by Countries in 2016
Figure South Africa Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Table Seattle Genetics/Takeda Antibody Drug Conjugate Basic Information List
Table Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Roche Antibody Drug Conjugate Basic Information List
Table Roche Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Roche Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Roche Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table ImmunoGen Antibody Drug Conjugate Basic Information List
Table ImmunoGen Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ImmunoGen Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure ImmunoGen Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure ImmunoGen Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Immunomedics Antibody Drug Conjugate Basic Information List
Table Immunomedics Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Immunomedics Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Immunomedics Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Immunomedics Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Pfizer Antibody Drug Conjugate Basic Information List
Table Pfizer Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Pfizer Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Celldex Therapeutics Antibody Drug Conjugate Basic Information List
Table Celldex Therapeutics Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celldex Therapeutics Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Celldex Therapeutics Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Celldex Therapeutics Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Millennium Pharmaceuticals Antibody Drug Conjugate Basic Information List
Table Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Bayer HealthCare Antibody Drug Conjugate Basic Information List
Table Bayer HealthCare Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer HealthCare Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bayer HealthCare Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Bayer HealthCare Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Mersana Therapeutics Antibody Drug Conjugate Basic Information List
Table Mersana Therapeutics Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Mersana Therapeutics Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Mersana Therapeutics Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Mersana Therapeutics Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Heidelberg Pharma Antibody Drug Conjugate Basic Information List
Table Heidelberg Pharma Antibody Drug Conjugate Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Heidelberg Pharma Antibody Drug Conjugate Sales (K Pcs) and Growth Rate (2012-2017)
Figure Heidelberg Pharma Antibody Drug Conjugate Sales Market Share in EMEA (2012-2017)
Figure Heidelberg Pharma Antibody Drug Conjugate Revenue Market Share in EMEA (2012-2017)
Table Oxford BioTherapeutics Antibody Drug Conjugate Basic Information List
Table Takeda Pharmaceutical Company Limited Antibody Drug Conjugate Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody Drug Conjugate
Figure Manufacturing Process Analysis of Antibody Drug Conjugate
Figure Antibody Drug Conjugate Industrial Chain Analysis
Table Raw Materials Sources of Antibody Drug Conjugate Major Manufacturers in 2016
Table Major Buyers of Antibody Drug Conjugate
Table Distributors/Traders List
Figure EMEA Antibody Drug Conjugate Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Antibody Drug Conjugate Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Antibody Drug Conjugate Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Antibody Drug Conjugate Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Antibody Drug Conjugate Sales Market Share Forecast by Region (2017-2022)
Table EMEA Antibody Drug Conjugate Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Antibody Drug Conjugate Revenue Market Share Forecast by Region (2017-2022)
Table Europe Antibody Drug Conjugate Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Antibody Drug Conjugate Sales Market Share Forecast by Countries (2017-2022)
Table Europe Antibody Drug Conjugate Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Antibody Drug Conjugate Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Antibody Drug Conjugate Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Antibody Drug Conjugate Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Antibody Drug Conjugate Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Antibody Drug Conjugate Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Antibody Drug Conjugate Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Antibody Drug Conjugate Sales Market Share Forecast by Countries (2017-2022)
Table Africa Antibody Drug Conjugate Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Antibody Drug Conjugate Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Antibody Drug Conjugate Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Antibody Drug Conjugate Sales Market Share Forecast by Type (2017-2022)
Table EMEA Antibody Drug Conjugate Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Antibody Drug Conjugate Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top